Category: Research

Will You Help Us Find a Cure for Sarcoidosis?

Will You Help Us Find a Cure for Sarcoidosis?

FSR strives to bring patients the most up-to-date information about sarcoidosis, but we can’t do that without you. Besides being a rare disease, affecting only 200,000 people in the U.S., sarcoidosis is commonly misdiagnosed. The limited data that does exist doesn’t...
Penn Medicine’s Sarcoidosis App Now on Android!

Penn Medicine’s Sarcoidosis App Now on Android!

We received a great deal of feedback asking when the app would be available on android devices. It has always been our goal to have the app available to everyone to give equal access to these sarcoidosis resources, as well as to help sarcoidosis researchers obtain the...
A Year in Review: FSR’s Research Initiatives

A Year in Review: FSR’s Research Initiatives

This year, FSR made some huge progress on our research agenda. This coming year promises to build on that progress, with new developments on several major projects that will lead to better understanding of the disease and therapies, more interest on the part of young...
Phase 1 Trial for New ILD Therapy Begins

Phase 1 Trial for New ILD Therapy Begins

The following is an excerpt from a press release by aTyr Pharma, Inc detailing their new study focusing on a potential therapy for treating interstitial lung diseases: SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics...
Rare Disease Research Consortium Announces Ambitious Goals

Rare Disease Research Consortium Announces Ambitious Goals

FSR is excited to share some breaking news from the world of rare disease research that could have a huge impact on the future of diagnosing and treating rare diseases worldwide. The International Rare Diseases Research Consortium (IRDiRC) has released an ambitious...